Antitumor agents--CLXXV. Anti-tubulin action of (+)-thiocolchicine prepared by partial synthesis.

(+)-Thiocolchicine (2b) was prepared from (+/-)-colchicine (1) in a five-step reaction sequence that included chromatographic separation of appropriate camphanylated diastereomers. Acid hydrolysis of the (+)-diastereomer, followed by acetylation, yielded the desired product 2b. (+)-Thiocolchicine has 15-fold lower inhibitory activity against tubulin polymerization than (-)-thiocolchicine, and is 29-fold less potent for inhibiting growth of human Burkitt lymphoma cells. The enantiomer 2a, prepared from the (-)-camphanylated diastereomer, had potent activity in all assays comparable to that of (-)-thiocolchicine prepared by other methods. These results support the hypothesis that the proper configuration of colchicine-related compounds is an important requirement for their anti-tubulin action.
AuthorsQ Shi, P Verdier-Pinard, A Brossi, E Hamel, K H Lee
JournalBioorganic & medicinal chemistry (Bioorg Med Chem) Vol. 5 Issue 12 Pg. 2277-82 (Dec 1997) ISSN: 0968-0896 [Print] ENGLAND
PMID9459025 (Publication Type: Journal Article, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Antineoplastic Agents
  • Tubulin Modulators
  • thiocholchicine
  • Colchicine
  • Antineoplastic Agents (chemical synthesis, pharmacology)
  • Chromatography, Thin Layer
  • Colchicine (analogs & derivatives, chemical synthesis, pharmacology)
  • Humans
  • Isomerism
  • Magnetic Resonance Spectroscopy
  • Models, Chemical
  • Tubulin Modulators
  • Tumor Cells, Cultured

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: